Latest Biotech News

An Alliance for Clinical Trials in Oncology study published in the Journal of Clinical Oncology reported high remission rates in older adults with B‑cell acute lymphoblastic leukemia using...

New agency hiring data show nearly 1,000 net departures from the FDA’s drug and biologics centers in the last quarter of fiscal 2025, marking an historic outflow that industry and policymakers say...

AstraZeneca and Daiichi Sankyo reported Datroway extended survival in patients with triple-negative breast cancer (TNBC) who were ineligible for immunotherapy, while Gilead’s Trodelvy continues to...

Exelixis disclosed Phase 3 results showing its oral TKI zanzalintinib, combined with Roche’s Tecentriq, reduced the risk of death by about 20% versus the standard comparator in previously treated...

Cancer early‑detection company Grail announced a securities purchase agreement expected to raise approximately $325 million in a private placement, citing new and existing institutional investors...

Genomics unveiled Mystra, an AI‑enabled human‑genetics platform designed to accelerate target discovery and clinical validation by harmonizing large GWAS and multiomic datasets. The company...

Roche presented Phase 3 data showing adjuvant Tecentriq (atezolizumab) guided by circulating tumor DNA (ctDNA) prolonged survival in a higher‑risk bladder cancer subset identified by blood...

Clinical trial data published in The New England Journal of Medicine showed the PRIMA wireless photovoltaic retinal implant restored reading vision for some patients with geographic atrophy from...

Presentations at ESMO and institutional studies from MD Anderson and the University of Florida reported that patients who received mRNA Covid‑19 vaccines within a defined window before starting...

Akeso and Summit Therapeutics reported that ivonescimab, a PD‑1xVEGF bispecific, reduced the risk of progression or death by roughly 40% versus a PD‑1 blocker in a Chinese frontline lung cancer...

NewLimit closed a $45 million financing round that included investment from Lilly Ventures and S32, positioning the anti‑aging startup to advance preclinical and early clinical programs. The...

Cyclana Bio raised £5 million in a pre‑seed round co‑led by NfX and Eka Ventures to develop a tissue‑level platform for identifying drug targets and functional disease models, initially focusing...

Grail said it entered a securities purchase agreement expected to generate about $325 million in gross proceeds, a financing the company said will fund commercial activities and reimbursement...

Cyclana Bio secured £5 million in pre‑seed funding co‑led by NfX and Eka Ventures to advance a tissue‑based discovery platform aimed at women’s health. The Cambridge startup plans to use the...

Bruker announced FDA 510(k) clearance for software, a sample‑prep process and expanded reference libraries for its MALDI Biotyper CA clinical microbiology system. The clearance covers the MBT...

Clinical trial data published in the New England Journal of Medicine and reporting from testing teams at UCL and Moorfields show the PRIMA wireless retinal implant can restore reading vision and...

Researchers from MD Anderson reported at ESMO and in retrospective analyses that patients with advanced lung or skin cancers who received an mRNA Covid vaccine within 100 days of starting immune...

The FDA granted approval for Roche’s CD20 antibody Gazyva to treat lupus nephritis, marking a new indication for the company’s marketed antibody. Roche said the approval expands therapeutic...

Sona Nanotech reported results from a first‑in‑human feasibility study treating 10 patients with immunotherapy‑resistant metastatic melanoma using its Targeted Hyperthermia Therapy (THT). By day...

BioCryst agreed to acquire Astria Therapeutics for $700 million, a deal that brings navenibart—a Phase 3 injectable antibody for hereditary angioedema (HAE)—into BioCryst’s pipeline. The company...